About Leo Guthart
Leo Guthart is a director at Neurona Therapeutics.
Leo Guthart reports to the SEC as a director or major shareholder of 5 public companies, including Oric Pharmaceuticals (ORIC), RAPT Therapeutics (RAPT) and Constellation Pharmaceuticals (CNST).
Leo Guthart first appears on SEC filings in 2007.
Experience
This experience comes from SEC filings. The years are when the filings name Leo Guthart in the role, so the role may have started earlier or lasted longer.
OI
Oric Pharmaceuticals, Inc.
10% owner
2020 · Public company (ORIC)
RI
RAPT Therapeutics, Inc.
10% owner
2019 – 2020 · Public company (RAPT)
CI
Constellation Pharmaceuticals Inc.
10% owner
2018 · Public company (CNST)
IC
Immune Design Corp.
10% owner
2016 – 2018 · Public company (IMDZ)
AI
Aptargroup, Inc.
Director
2007 – 2014 · Public company (ATR)
Key Colleagues at Startups
The people Leo Guthart works with at each company, as listed on that company's latest Form D.
Neurona Therapeutics, Inc. · Form D, Apr 4, 2025
PS
Peter Svennilson
Director
TK
Tim Kutzkey
Director
BM
Brad Margus
Director
CN
Cory Nicholas
Executive officer, director and promoter
JS
James Stutz
Chief Financial Officer
RK
Ray Kelleher
Director
EW
Erica Whittaker
Director